Thalidomide, A Rational Agent for Treatment of Multicentric Reticulohistiocytosis
A patient with Multifocal Reticulohistiocytosis (MRH) of skin and joints failed treatment with etanercept, methotrexate, hydroxychloroquine, prednisone, bisphosphonates and hydroxyzine. Long term treatment with thalidomide led to marked improvement in joint and cutaneous manifestations.
Published In/Presented At
Zinn DJ, Eckstein O, Olsen ML, Allen CE, McClain KL (2019) Thalidomide, A Rational Agent for Treatment of Multicentric Reticulohistiocytosis. Dermatol Case Rep 4: 152.
Hematology | Medicine and Health Sciences | Oncology | Pediatrics
Peer Reviewed for front end display
Department of Pediatrics, Department of Pediatrics Faculty